DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Octreotate
Octreotate
Targeting Somatostatin Receptors: Preclinical Evaluation of Novel 18F-Fluoroethyltriazole-Tyr3-Octreotate Analogs for PET
Alshaer Danah Mahdi 2020.Pdf (14.70Mb)
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Tanibirumab (CUI C3490677) Add to Cart
Downloaded from Bioscientifica.Com at 09/23/2021 09:50:19AM Via Free Access
Multi-Discipline Review(S)
Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
Use of DOTATATE PET/CT Scan in the Diagnosis and Staging Of
Selected Cases 2018
Design and Synthesis of FVIII- and Upar-Selective Ligands and Cross- Linked Polymers As Media for NMR-Spectroscopy
Assessment Report
Comparison of the Therapeutic Response to Treatment with a 177-Lutetium Labeled Somatostatin Receptor
[177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Somatostatin Receptors and Their Ligands in the Human Immune System
763.Full.Pdf
WO 2015/057852 Al 23 April 2015 (23.04.2015) P O P C T
GUIDELINES Ga68dota-X-Apr-26-2010
Somatostatin, Cortistatin and Their Receptors in Tumours Marco Volante, R
Top View
Appendix 1: Literature Search Strategy
Peptides and Oligonucleotides) Harvest
Targeted Cancer Therapy: What's New in the Field of Neuroendocrine
260.Full.Pdf
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuro
Treatment with the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival Dik J
Optumrx Brand Pipeline Forecast
The Diagnosis of Neuroendocrine Tumours: an Endocrine Perspective Nöroendokrin Tümörlerin Tanısına Endokrin Bakış
177Lu-DOTA-Octreotate Radionuclide Therapy of Neuroendocrine Tumours
Management of the Hormonal Syndrome of Neuroendocrine Tumors
Thesis Final.Indd
PRRT for Nets
Managing Dismounted Complex Blast Injuries in Military & Civilian Settings
Neuroendocrine Tumours
Orphan Drug Designations and Approvals List As of 12‐01‐2014
Novel Imaging Tools Reveal the Dynamics of the Myocardial Growth Hormone Secretagogue Receptor in Heart Disease and Heart Failure
Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P
Peptide Therapeutics 2.0
Somatostatin Receptor Antagonists for Imaging and Therapy
Radiolabelling of Glucose-Tyr3-Octreotate with 125I and Analysis of Its Metabolism in Rats: Comparison with Radiolabelled DOTA-Tyr3-Octreotate
Molecular Imaging Probes Derived from Natural Peptides
8Th International Pituitary Congress Will Be Held in New York City from June 22 Through June 25, Immediately Following the ENDO 2003 Meeting in Philadelphia
Long-Term Efficacy, Survival, and Safety of [ Lu-DOTA ,Tyr ]Octreotate in Patients with Gastroenteropancreatic and Bronchial
Scientific Programme
Case Studies on Fxiiia Inhibitor Tridegin and Μ-Conotoxin PIIIA
Somatostatin Receptor-Based Imaging and Therapy of Gastroenteropancreatic Neuroendocrine Tumors
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016